[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349441-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349441-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","enhanced-detection-of-bladder-cancer-using-combined-circulating-tumor-cells-urine-derived-epithelial-cells-and-molecular-biomarkers","Enhanced detection of bladder cancer using combined circulating tumor cells, urine-derived epithelial cells, and molecular biomarkers","","Purpose: Sensitivity of bladder cancer detection based on a single biomarker from a single sample type is limited. Methods: The study enrolled 85 bladder cancer patients and 30 healthy individuals, isolating urine-derived epithelial cells (UDECs) and circulating tumor cells (CTCs) from urine and analyzing them with PD-L1 assay and FISH for chromosomes 7 and 8, alongside conventional urine exfoliation cytology (UEC). Results: Detection rates were improved by combining biomarkers across sample types, reaching up to 96.5%. Conclusion: Integrating multiple biomarkers from distinct sample types significantly enhances detection sensitivity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/enhanced-detection-of-bladder-cancer-using-combined-circulating-tumor-cells-urine-derived-epithelial-cells-and-molecular-biomarkers/349441/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/enhanced-detection-of-bladder-cancer-using-combined-circulating-tumor-cells-urine-derived-epithelial-cells-and-molecular-biomarkers/349441.png","ImageObject",300,407,{"name":42,"@type":43},"Blitz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in bladder cancer detection?","Question",{"text":63,"@type":64},"Detection sensitivity is limited when relying on a single biomarker from one sample type. The study investigates whether combining multiple biomarkers from different clinical samples can improve sensitivity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were samples collected and which assays were used?",{"text":68,"@type":64},"Urine and blood samples were collected to isolate urine-derived epithelial cells (UDECs) and circulating tumor cells (CTCs). Cells were analyzed using a PD-L1 assay and fluorescence in situ hybridization (FISH) targeting chromosomes 7 and 8, with urine exfoliation cytology (UEC) performed in parallel.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key results for detection rates?",{"text":72,"@type":64},"CTC analysis showed a higher detection rate (78.6%) than UEC (36.7%). Combined approaches using UDEC-FISH with CTC analysis achieved 94.1%, and three-marker combinations reached 96.5% or 90.6%.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349441,1790732981,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Journal of Cancer Research and Clinical Oncology (2026) 152:131  \n[https://doi.org/10.1007/s00432-026-06469-x](https://doi.org/10.1007/s00432-026-06469-x)  \nRESEARCH  \nEnhanced detection of bladder cancer using combined circulating tumor cells, urine-derived epithelial cells, and molecular biomarkers  \nZhijie Jiang1,2 · Cheng Yuan3 · Honggang Yuan2 · Chengchen Qin4 · Yanqing Li5 · Yuanyuan Hu4 · Changsheng Sun5 · Jiangping Deng5 · Feng Deng5 · Chunyan Li4 · Xin Li6 · Jianjun Zheng6 · Xingguang Luo7 · Xinghua Pan8 · Kejun Yan2 · Glenn Deng6  \nReceived: 8 February 2026 / Accepted: 23 March 2026 © The Author(s) 2026  \nAbstract  \nPurpose The sensitivity of bladder cancer detection using a single biomarker from single sample type is limited. This study aimed to investigate whether a combined approach utilizing multiple biomarkers from different clinical samples could improve detection sensitivity.  \nMethods A total of 85 patients with bladder cancer and 30 healthy individuals were enrolled in this study. Urine and blood samples were collected for the isolation of urine-derived epithelial cells (UDECs) and circulating tumor cells (CTCs) . These cells were then analyzed via PD-L1 assay and fluorescence in situ hybridization (FISH) targeting chromosomes 7 and 8. In parallel, matched urine samples from patients underwent conventional urine exfoliation cytology testing (UEC) . All data were analyzed in conjunction with pathological information using specialized statistical software.  \nResults Analysis of CTCs demonstrated a significantly higher bladder cancer detection rate (78.6%) compared to UEC (36.7%) . The combination of UDEC-FISH and CTC analysis utilizing urine and blood samples achieved a higher detection rate (94.1%) than the combination of UDEC-FISH with UEC performed on the same urine sample (79.8%) . Furthermore, combined analysis of three markers of CTC, UEC, and UDEC-FISH (96.5%) or CTC, UEC, and UDEC-PD-L1 (90.6%) yielded significantly higher detection rates than any single biomarker analysis alone.  \nConclusion Integrating multiple biomarkers from distinct sample types significantly enhances the detection sensitivity for bladder cancer.  \nKeywords Chromosome FISH (fluorescence in situ hybridization) analysis · Circulating tumor cells · Programmed cell death ligand 1 (PD-L1) · Urine-derived epithelial cells (UDECs) · Urine-derived tumor cells (UDTCs) · Urinary exfoliative cytology (UEC) · Bladder Cancer diagnosis  \nIntroduction  \nBladder cancer ranks as the ninth most common cancer globally, with approximately 6.13 million new cases and 2.3 million deaths reported annually worldwide (Bray et al. 2024) . It is also one of the most common tumors ofthe urinary system, with the majority of patients diagnosed with non-muscle invasive bladder cancer (NMIBC) (Hoffmann and Schulz 2021; Miyazaki and Nishiyama 2017) . The conventional diagnostic methods for urothelial carcinoma  \ninclude endoscopy, urinary exfoliative cytology, or a combination of both; however, their detection rates remain low with limited heterogeneity (Białek et al. 2022) . These methods have limited sensitivity and rely heavily on experienced examiners and precise instruments, primarily detecting high-grade bladder cancer or preinvasive lesions (Fiorentino et al. 2023) . Malignant cells in bladder lesions typically exhibit weak cohesion, allowing single tumor cells to detach from the primary lesion and shed into the urine. Moreover, urine contains relatively few other cell types,  \nZhijie Jiang, Cheng Yuan, Honggang Yuan, Chengchen Qin and Yanqing Li contributed equally to this work.  \nExtended author information available on the last page of the article  \ntheoretically facilitating the screening of tumor cells in urine samples (Zhang et al. 2021) . Circulating tumor cell (CTC) detection is also applied in screening cancers of the urinary system, including renal pelvic carcinoma, bladder cancer, and ureteral carcinoma (Wang and Ding 2023; Koguchi et al. 2022; W","cbCaifFZEfpvfIqd","https://ap.wps.com/l/cbCaifFZEfpvfIqd","pdf",1324131,"English","# Abstract\n# Introduction\n## Conventional diagnostic methods and limitations\n## Rationale for CTCs and urine-derived tumor cells","[{\"question\":\"What problem does the study address in bladder cancer detection?\",\"answer\":\"Detection sensitivity is limited when relying on a single biomarker from one sample type. The study investigates whether combining multiple biomarkers from different clinical samples can improve sensitivity.\"},{\"question\":\"How were samples collected and which assays were used?\",\"answer\":\"Urine and blood samples were collected to isolate urine-derived epithelial cells (UDECs) and circulating tumor cells (CTCs). Cells were analyzed using a PD-L1 assay and fluorescence in situ hybridization (FISH) targeting chromosomes 7 and 8, with urine exfoliation cytology (UEC) performed in parallel.\"},{\"question\":\"What were the key results for detection rates?\",\"answer\":\"CTC analysis showed a higher detection rate (78.6%) than UEC (36.7%). Combined approaches using UDEC-FISH with CTC analysis achieved 94.1%, and three-marker combinations reached 96.5% or 90.6%.\"}]","Enhanced detection of bladder cancer using combined circulating tumor cells, urine-derived epithelial cells, and molecular biomarkers | PDF",1790083322,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb899330a378da9600861b8cefa15522.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d434fd438d7868e7a2a5fef2bfebc7c.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37985b3fd865c21bd4b731c2db62f213.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ffb2889e34230eb2df57f5e73819d6f.webp",980,1301]